Arthritis & Rheumatic Diseases

Medicine & Life Sciences

1. Acquired Immunodeficiency Syndrome 5%
2. Ankylosing Spondylitis 100%
3. Anterior Uveitis 8%
4. Antirheumatic Agents 12%
5. Arthritis 11%
6. Back Pain 5%
7. Baths 8%
8. bimekizumab 6%
9. Biological Products 5%
10. Blau syndrome 6%
11. Clinical Trials 5%
12. Cytokines 8%
13. Fatigue 6%
14. Fibromyalgia 7%
15. Gastrointestinal Microbiome 8%
16. Genes 5%
17. golimumab 25%
18. guselkumab 18%
19. HIV 16%
20. HIV Infections 6%
21. HIV-1 7%
22. HLA-B27 Antigen 5%
23. India 11%
24. Infections 5%
25. Inflammation 10%
26. Infliximab 5%
27. Interleukin-17 13%
28. ixekizumab 23%
29. Joints 9%
30. Microbiota 11%
31. Pain 6%
32. Patient Reported Outcome Measures 7%
33. Placebos 33%
34. Population 5%
35. Psoriasis 15%
36. Psoriatic Arthritis 51%
37. Quality of Life 7%
38. Randomized Controlled Trials 9%
39. Rheumatoid Arthritis 26%
40. Rheumatologists 10%
41. Rheumatology 19%
42. Sacroiliac Joint 5%
43. Sacroiliitis 6%
44. Safety 22%
45. secukinumab 38%
46. Signs and Symptoms 6%
47. Spine 6%
48. Systemic Lupus Erythematosus 16%
49. Systemic Scleroderma 5%
50. T-Lymphocytes 9%
51. Therapeutics 17%
52. Tuberculosis 6%
53. Tumor Necrosis Factor Inhibitors 29%
54. Tumor Necrosis Factor-alpha 8%
55. upadacitinib 12%
56. Uveitis 11%
57. Vasculitis 5%